American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 259-268 , February 2010

Is Presence of ANCA in Crescentic IgA Nephropathy a Coincidence or Novel Clinical Entity? A Case Series

  • Christos Bantis, MD

      Affiliations

    • Department of Nephrology, Heinrich-Heine University of Düsseldorf, Germany
    • Department of Nephrology, Aristotle University of Thessaloniki, Greece
  • ,
  • Maria Stangou, MD

      Affiliations

    • Department of Nephrology, Aristotle University of Thessaloniki, Greece
  • ,
  • Christoph Schlaugat, MD

      Affiliations

    • Department of Nephrology, Städisches Klinikum Solingen, University of Cologne, Germany
  • ,
  • Efstathios Alexopoulos, MD, PhD

      Affiliations

    • Deceased.
    • Department of Nephrology, Aristotle University of Thessaloniki, Greece
  • ,
  • Aphroditi Pantzaki, MD

      Affiliations

    • Department of Nephrology, Aristotle University of Thessaloniki, Greece
  • ,
  • Dimitrios Memmos, MD, PhD

      Affiliations

    • Department of Nephrology, Aristotle University of Thessaloniki, Greece
  • ,
  • Katrin Ivens, MD, PhD

      Affiliations

    • Department of Nephrology, Heinrich-Heine University of Düsseldorf, Germany
  • ,
  • Peter J. Heering, MD, PhD

      Affiliations

    • Department of Nephrology, Heinrich-Heine University of Düsseldorf, Germany
    • Department of Nephrology, Städisches Klinikum Solingen, University of Cologne, Germany
    • Corresponding Author InformationAddress correspondence to Peter J. Heering, MD, PhD, Department of Nephrology, Staedtisches Klinikum Solingen, Gotenstrasse 1, 42653 Solingen, Germany

Received 31 March 2009 ,Accepted 28 September 2009.

References 

  1. Harper SJ, Pringle JH, Wicks AC, et al. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int. 1994;45(3):836–844
  2. Harper SJ, Allen AC, Pringle JH, Feehally J. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol. 1996;49(1):38–42
  3. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol. 1993;104:172–182
  4. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29(6):829–842
  5. Tumlin JA, Hennigar RA. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy. Semin Nephrol. 2004;24(3):256–268
  6. O'Donoghue DJ, Nusbaum P, Noel LH, Halbwachs-Mecarelli L, Lesavre P. Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura. Nephrol Dial Transplant. 1992;7(6):534–538
  7. Allmaras E, Nowack R, Andrassy K, Waldherr R, van der Woude F, Ritz E. Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol. 1997;48(5):269–273
  8. Martin SJ, Audrain MA, Baranger T, et al. Recurrence of immunoglobulin A nephropathy with immunoglobulin A antineutrophil cytoplasmic antibodies following renal transplantation. Am J Kidney Dis. 1997;29(1):125–131
  9. McGregor D, Lynn KL, Robson R. Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies responding to immunosuppression. Clin Nephrol. 1998;50(1):64
  10. Ramirez SB, Rosen S, Niles J, Somers MJ. IgG antineutrophil cytoplasmic antibodies in IgA nephropathy: a clinical variant?. Am J Kidney Dis. 1998;31(2):341–344
  11. Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis. 2000;36(4):709–718
  12. Tagboto S, Carr S, Varghese A, Allen A, Feehally J, Furness P. IgA nephropathy, antineutrophil cytoplasmic antibodies and crescentic glomerulonephritis in a patient with the Hermansky-Pudlak syndrome. Am J Nephrol. 2001;21(1):58–62
  13. Lui SL, Chan KW, Yip PS, Chan TM, Lai KN, Lo WK. Simultaneous occurrence of diabetic glomerulosclerosis, IgA nephropathy, crescentic glomerulonephritis, and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity in a Chinese patient. Am J Kidney Dis. 2002;40(4):E14
  14. Jimbo R, Ubara Y, Tagami T, et al. A pediatric occurrence of crescentic glomerulonephritis associated with antineutrophil cytoplasmic antibodies and mesangial IgA deposits. Clin Nephrol. 2007;68(2):104–108
  15. Ogawa N, Yano S, Yamane Y, et al. MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomy. Clin Exp Nephrol. 2007;11(4):326–331
  16. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis (EC/BCR Project for ANCA Assay Standardization). Kidney Int. 1998;53(3):743–753
  17. Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110(7):955–963
  18. Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int. 2003;63(3):1079–1085
  19. Waldherr R, Rambausek M, Duncker WD, Ritz E. Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant. 1989;4(11):943–946
  20. Lai FM, Li EK, Suen MW, Lui SF, Li PK, Lai KN. Pulmonary hemorrhage (A fatal manifestation in IgA nephropathy). Arch Pathol Lab Med. 1994;118(5):542–546
  21. Medcalf JF, Brownjohn AM, Turney JH. Pulmonary haemorrhage in association with IgA nephropathy. Nephrol Dial Transplant. 1996;11(6):1148–1149
  22. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66(4):1535–1540

 Originally published online as doi:10.1053/j.ajkd.2009.09.031 on December 31, 2009.

PII: S0272-6386(09)01321-3

doi: 10.1053/j.ajkd.2009.09.031

American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 259-268 , February 2010